Applied Clinical Research, Clinical Trials and Regulatory Affairs, Volume 2 - Number 3

Meet Our Editorial Board Member:

, 2(3): 113

Vladimir Misik

DOI: 10.2174/2213476X0203160218165330


Editorial (Thematic Issue: Regulatory Stratagem in Health Care Environment - Need for Success)

, 2(3): 114

Harish Dureja

DOI: 10.2174/2213476X0203160218165912

Pharma Emerging Market’s Scaning by Look and Feel of its Opportunities and Challenges

, 2(3): 115 - 122

Parveen Kumar, Swagat Tripathy and Harish Dureja

DOI: 10.2174/2213476X03666151125220257

Comparative Account of Quality Management and Regulatory Aspects of Products with Health Claims: Existing Approaches and Future Challenges for Probiotics and Herbal Products

, 2(3): 123 - 132

Malika Arora and Ashish Baldi

DOI: 10.2174/2213476X02666151103213351

Drug and Cosmetic Amendment Bill in India: A Promising Hope for Healthy Medical Device Regulatory Environment

, 2(3): 133 - 136

Dimple Chaudhary, Swagat Tripathy and Harish Dureja

DOI: 10.2174/2213476X02666150908210025

Regulations of Cosmetics Across the Globe

, 2(3): 137 - 144

Shivaji Rai, Apeksha Gupta and Vikas Punetha

DOI: 10.2174/2213476X03666151125220117

Product Life Cycle Management for Pharmaceutical Innovation

, 2(3): 145 - 152

Swagat Tripathy, Vandana Prajapati and VijayaKumar Sengodan Guruswamy

DOI: 10.2174/2213476X03666160112001136

Anti-Monopoly and Competition Laws - Impact on the Indian Pharmaceutical Industry

, 2(3): 153 - 157

Prerna Kaushik, Swagat Tripathy, Rishi Sharma and Harish Dureja

DOI: 10.2174/2213476X0203160219101526

Regulatory Overview of Biosimilars: Current Scenario and Future Opportunities

, 2(3): 158 - 164

Ajmer S. Grewal, Viney Lather, Shashikant Bhardwaj and Deepti Pandita

DOI: 10.2174/2213476X03666151221210747

Good Manufacturing Practice Regulations for Probiotic Based Pharmaceuticals: Current Scenario and Suggestive Recommendations

, 2(3): 165 - 175

Malika Arora and Ashish Baldi

DOI: 10.2174/2213476X03666160127001910

Enhanced Globalization and Speed to Market for Innovative Medicines

, 2(3): 176 - 185

Leticia Delgado-Herrera, Natalie Boone, Judy Kannenberg, Marcel van Gelderen, Keiichirou Ogawa, Mary Beth Blauwet, Marlowe J Schneidkraut, Sabine Agena, Raymond van Aarle, Yosuke Kubota, Marjan van der Werf-Pieters, Ivanka Baaij and Salim Mujais

DOI: 10.2174/2213476X03666160127001615

Acknowledgements to Reviewers:

, 2(3): 186

DOI: 10.2174/2213476X0203160219102659

Webmaster Contact:
Copyright © 2018 Bentham Science